Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Oct;46(4):625–634. doi: 10.1038/bjc.1982.247

Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

S Swinburne, M Moore, P Cole
PMCID: PMC2011179  PMID: 7138768

Abstract

Human bronchoalveolar macrophages were separated from other free lung cells by density sedimentation on Percoll gradients. They were then tested for cytotoxicity against the human lung adenocarcinoma cell line A549, using a Selenomethionine-75 post-labelling assay. The cytotoxicity of the macrophages increased as the effector:target cell ratio was increased, approaching 100% at 20:1. There was no significant difference in the cytotoxicity of macrophages isolated from the lungs of bronchial-carcinoma or non-carcinoma patients. The highly cytotoxic nature of the macrophages was not due to selection of a more potent cytotoxic subpopulation of macrophages on the Percoll gradient, nor to a generally elevated activation of the macrophages due to the pathological conditions in the patients' lungs. An attempt to determine whether low concentrations of macrophages could potentiate target-cell growth proved negative. Cytotoxicity of macrophages for cultured lung target cells was not restricted to A549 cells and is not in accordance with the view that defective bronchoalveolar macrophage cytotoxicity contributes to the emergence of bronchial neoplasia.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binderup L., Bramm E., Arrigoni-Martelli E. Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro. Experientia. 1979 Sep 15;35(9):1230–1232. doi: 10.1007/BF01963307. [DOI] [PubMed] [Google Scholar]
  2. Bordignon C., Avallone R., Peri G., Polentarutti N., Mangioni C., Mantovani A. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages. Clin Exp Immunol. 1980 Aug;41(2):336–342. [PMC free article] [PubMed] [Google Scholar]
  3. Brooks C. G., Rees R. C., Robins R. A. Studies on the microcytotoxicity test. II. The uptake of amino acids ([3H]leucine or [75Se]methionine) but not nucleosides ([3H]thymidine or [125I]IUdR) or 51CrO24-provides a direct and quantitative measure of target cell survival in the presence of lymphoid cells. J Immunol Methods. 1978;21(1-2):111–124. doi: 10.1016/0022-1759(78)90228-4. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Cole P., Turton C., Lanyon H., Collins J. Bronchoalveolar lavage for the preparation of free lung cells: technique and complications. Br J Dis Chest. 1980 Jul;74(3):273–278. doi: 10.1016/0007-0971(80)90055-8. [DOI] [PubMed] [Google Scholar]
  6. DeLustro F., Sherer G. K., LeRoy E. C. Human monocyte stimulation of fibroblast growth by a soluble mediator(s). J Reticuloendothel Soc. 1980 Dec;28(6):519–532. [PubMed] [Google Scholar]
  7. Evans R. Host cells in transplanted murine tumors and their possible relevance to tumor growth. J Reticuloendothel Soc. 1979 Oct;26(4):427–437. [PubMed] [Google Scholar]
  8. Finley T. N., Ladman A. J. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med. 1972 Feb 3;286(5):223–227. doi: 10.1056/NEJM197202032860501. [DOI] [PubMed] [Google Scholar]
  9. Fischer P., Vetterlein M. Establishment and cytogenetic analysis of a cell line derived from a human epithelioma of the lung.. Oncology. 1977;34(5):205–208. doi: 10.1159/000225224. [DOI] [PubMed] [Google Scholar]
  10. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  11. Gorman N. T. Alveolar macrophage cytotoxicity in dogs following intravenous BCG. Eur J Cancer. 1979 Aug;15(8):1051–1059. doi: 10.1016/0014-2964(79)90293-7. [DOI] [PubMed] [Google Scholar]
  12. Greenburg G. B., Hunt T. K. The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages. J Cell Physiol. 1978 Dec;97(3 Pt 1):353–360. doi: 10.1002/jcp.1040970310. [DOI] [PubMed] [Google Scholar]
  13. Hardin J. A., Downs J. T. Isolation of human monocytes on re-orienting gradients of Percoll. J Immunol Methods. 1981;40(1):1–6. doi: 10.1016/0022-1759(81)90074-0. [DOI] [PubMed] [Google Scholar]
  14. Harris J. O., Swenson E. W., Johnson J. E., 3rd Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest. 1970 Nov;49(11):2086–2096. doi: 10.1172/JCI106426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hocking W. G., Golde D. W. The pulmonary-alveolar macrophage (first of two parts). N Engl J Med. 1979 Sep 13;301(11):580–587. doi: 10.1056/NEJM197909133011104. [DOI] [PubMed] [Google Scholar]
  16. Hocking W. G., Golde D. W. The pulmonary-alveolar macrophage (second of two parts). N Engl J Med. 1979 Sep 20;301(12):639–645. doi: 10.1056/NEJM197909203011205. [DOI] [PubMed] [Google Scholar]
  17. Hogg N., Balkwill F. R. Species restriction in cytostatic activity of human and murine monocytes and macrophages. Immunology. 1981 May;43(1):197–204. [PMC free article] [PubMed] [Google Scholar]
  18. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  19. Jerrells T. R., Dean J. H., Richardson G., Cannon G. B., Herberman R. B. Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients. Int J Cancer. 1979 Jun 15;23(6):768–776. doi: 10.1002/ijc.2910230606. [DOI] [PubMed] [Google Scholar]
  20. Keller R. Major changes in lymphocyte proliferation evoked by activated macrophages. Cell Immunol. 1975 Jun;17(2):542–551. doi: 10.1016/s0008-8749(75)80058-x. [DOI] [PubMed] [Google Scholar]
  21. Kurisu M., Yamazaki M., Mizuno D. In vitro induction of antibody-dependent cytotoxic macrophages by the local anesthetic lidocaine. Microbiol Immunol. 1978;22(10):631–637. doi: 10.1111/j.1348-0421.1978.tb00413.x. [DOI] [PubMed] [Google Scholar]
  22. Lee K. C., Berry D. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth. J Immunol. 1977 May;118(5):1530–1540. [PubMed] [Google Scholar]
  23. Leibovich S. J., Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976 Sep;84(3):501–514. [PMC free article] [PubMed] [Google Scholar]
  24. Lemarbre P., Hoidal J., Vesella R., Rinehart J. Human pulmonary macrophage tumor cell cytotoxicity. Blood. 1980 Apr;55(4):612–617. [PubMed] [Google Scholar]
  25. Lohmann-Matthes M. L., Kolb B., Meerpohl H. G. Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF). Cell Immunol. 1978 Dec;41(2):231–239. doi: 10.1016/0008-8749(78)90221-6. [DOI] [PubMed] [Google Scholar]
  26. Mantovani A. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity. Int J Cancer. 1978 Dec;22(6):741–746. doi: 10.1002/ijc.2910220617. [DOI] [PubMed] [Google Scholar]
  27. Mantovani A., Jerrells T. R., Dean J. H., Herberman R. B. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int J Cancer. 1979 Jan 15;23(1):18–27. doi: 10.1002/ijc.2910230105. [DOI] [PubMed] [Google Scholar]
  28. Moore K., Moore M. Systemic and in-situ natural killer activity in tumour-bearing rats. Br J Cancer. 1979 Jun;39(6):636–647. doi: 10.1038/bjc.1979.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nathan C. F., Terry W. D. Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages. J Exp Med. 1975 Oct 1;142(4):887–902. doi: 10.1084/jem.142.4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pertoft H., Johnsson A., Wärmegård B., Seljelid R. Separation of human monocytes on density gradients of Percoll. J Immunol Methods. 1980;33(3):221–229. doi: 10.1016/0022-1759(80)90209-4. [DOI] [PubMed] [Google Scholar]
  31. Rhodes J., Plowman P., Bishop M., Lipscomb D. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression. J Natl Cancer Inst. 1981 Mar;66(3):423–429. [PubMed] [Google Scholar]
  32. Roder J. C., Lohmann-Matthes M. L., Domzig W., Kiessling R., Haller O. A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur J Immunol. 1979 Apr;9(4):283–288. doi: 10.1002/eji.1830090407. [DOI] [PubMed] [Google Scholar]
  33. Ryning F. W., Krahenbuhl J. L., Remington J. S. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages. Immunology. 1981 Apr;42(4):513–519. [PMC free article] [PubMed] [Google Scholar]
  34. Serio C., Gandour D. M., Walker W. S. Macrophage functional heterogeneity: evidence for different antibody-dependent effector cell activities and expression of Fc-receptors among macrophage subpopulations. J Reticuloendothel Soc. 1979 Feb;25(2):197–206. [PubMed] [Google Scholar]
  35. Ulmer A. J., Flad H. D. Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. J Immunol Methods. 1979;30(1):1–10. doi: 10.1016/0022-1759(79)90268-0. [DOI] [PubMed] [Google Scholar]
  36. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis. 1977 Jul;116(1):73–125. doi: 10.1164/arrd.1977.116.1.73. [DOI] [PubMed] [Google Scholar]
  37. Warr G. A., Martin R. R. Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking. Infect Immun. 1974 Apr;9(4):769–771. doi: 10.1128/iai.9.4.769-771.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wing E. J., Remington J. S. Activated macrophages pre-incubated in vitro enhance rather than suppress mitogen-stimulated lymphocyte transformation. Immunology. 1980 Jun;40(2):239–246. [PMC free article] [PubMed] [Google Scholar]
  39. Yeager H., Jr, Zimmet S. M., Schwartz S. L. Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers. J Clin Invest. 1974 Aug;54(2):247–251. doi: 10.1172/JCI107759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zwilling B. S., Campolito L. B. Destruction of tumor cells by BCG-activated alqolar macrophages. J Immunol. 1977 Sep;119(3):838–841. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES